Increasing Membrane Cholesterol Level Increases the Amyloidogenic Peptide by Enhancing the Expression of Phospholipase C
Journal of Neurodegenerative Diseases · 2013
DOI: 10.1155/2013/407903 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurodegenerative Diseases, 2013. Verfasst von Yoon Sun Chun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon 440-746, Republic of Korea. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: NINDS NIH HHS, Basic Science Research Program, National Research Foundation of Korea.
Abstract (Originalsprache)
Cerebral elevation of 42-residue amyloid β -peptide (A β 42) triggers neuronal dysfunction in Alzheimer's disease (AD). Even though a number of cholesterol modulating agents have been shown to affect A β generation, the role of cholesterol in the pathogenesis of AD is not clear yet. Recently, we have shown that increased membrane cholesterol levels downregulates phosphatidylinositol 4,5-bisphosphate (PIP 2 ) via activation of phospholipase C (PLC). In this study, we tested whether membrane cholesterol levels may affect the A β 42 production via changing PIP 2 levels. Increasing membrane cholesterol levels decreased PIP 2 and increased secreted A β 42. Supplying PIP 2 , by using a PIP 2 -carrier system, blocked the effect of cholesterol on A β 42. We also found that cholesterol increased the expressions of β 1 and β 3 PLC isoforms (PLC β 1, PLC β 3). Silencing the expression of PLC β 1 prevented the effects of cholesterol on PIP 2 levels as well as on A β 42 production, suggesting that increased membrane cholesterol levels increased secreted A β 42 by downregulating PIP 2 via enhancing the expression of PLC β 1. Thus, cholesterol metabolism may be linked to A β 42 levels via PLC β 1 expression and subsequent changes in PIP 2 metabolism.
Autor:innen und Institutionen
- Department of Physiology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon 440-746, Republic of Korea.
- Department of Pathology, Columbia University Medical Center, New York, NY 10032, USA.
Förderung
- NINDS NIH HHS
- Basic Science Research Program
- National Research Foundation of Korea
- Ministry of Education, Science and Technology
- Samsung
- National Institutes of Health
Zitieren
APA
Chun, Y. S., Oh, H. G., Park, M. K., Kim, T. W., & Chung, S. (2013). Increasing Membrane Cholesterol Level Increases the Amyloidogenic Peptide by Enhancing the Expression of Phospholipase C. Journal of Neurodegenerative Diseases. https://doi.org/10.1155/2013/407903
Vancouver
Chun YS, Oh HG, Park MK, Kim TW, Chung S. Increasing Membrane Cholesterol Level Increases the Amyloidogenic Peptide by Enhancing the Expression of Phospholipase C. Journal of Neurodegenerative Diseases. 2013. doi:10.1155/2013/407903
BibTeX
@article{Chun2013,
author = {Chun, Yoon Sun and Oh, Hyun Geun and Park, Myoung Kyu and Kim, Tae-Wan and Chung, Sungkwon},
title = {Increasing Membrane Cholesterol Level Increases the Amyloidogenic Peptide by Enhancing the Expression of Phospholipase C},
journal = {Journal of Neurodegenerative Diseases},
year = {2013},
doi = {10.1155/2013/407903}
}
EUVIMED